Team:KULeuven/Freezer

From 2009.igem.org

(Difference between revisions)
(vanillin synthesis)
(Blue light receptor)
Line 37: Line 37:
| {{kulpart|BBa_K238000}}||/||PCR BLR promoter region (360bp)||4 microcentrifuge tubes||||||july 30
| {{kulpart|BBa_K238000}}||/||PCR BLR promoter region (360bp)||4 microcentrifuge tubes||||||july 30
|-
|-
-
| {{iGempart|BBa_pSB3K3-P1010}}||/||kanamycine pasmide backbone|| taken from plates || 13μl ||||aug 11
+
| {{iGempart|BBa_pSB3K3-P1010}}|| pSB3K3 ||kanamycine plasmide backbone|| taken from plates || 13μl ||||aug 11
|-
|-
| {{iGempart|BBa_J23101}}||/||constitutive promotor||taken from plates || 13μl ||||aug 11
| {{iGempart|BBa_J23101}}||/||constitutive promotor||taken from plates || 13μl ||||aug 11
|-
|-
-
| {{iGempart|BBa_K238013}}||/||Exact blue light promotor ||cut with EcoRI and SpeI || 26μl ||||aug 12
+
| {{iGempart|BBa_K238013}}||/||Exact blue light promotor ||cut with EcoRI and SpeI || 26μl || 27 ng/μl /||aug 12
|}
|}

Revision as of 12:12, 12 August 2009

Contents

Blue light receptor

part plasmid description status μl left concentration date
MC4100 / strain of E.coli july 24
2171 / forward primer for 90µl 20μM july 24
2172 / reverse primer for 90µl 20μM july 24
2171 / forward primer for 100μM july 24
2172 / reverse primer for 100μM july 24
2260 / forward primer for 45µl 20μM aug 10
2261 / reverse primer for 45µl 20μM aug 10
2260 / forward primer for 100μM aug 10
2261 / reverse primer for 100μM aug 10
pSB1A2GFP + rbs + terminatorrestricted with EcoRI and XbaIjuly 29
/BLR promoter region (1:200 adn 1:500)restricted with EcoRIjuly 29
/PCR BLR promoter region (360bp)4 microcentrifuge tubesjuly 30
Template:IGempart pSB3K3 kanamycine plasmide backbone taken from plates 13μl aug 11
Template:IGempart/constitutive promotortaken from plates 13μl aug 11
Template:IGempart/Exact blue light promotor cut with EcoRI and SpeI 26μl 27 ng/μl /aug 12

Key/antikey/lock

part plasmid description status μl left concentration date
/GFP with LVA tagpurifiedjuly 28
/tetR promoter purifiedjuly 28

vanillin synthesis

part plasmid description status μl left concentration date
pSB1A2ech + rbspurified plasmid (C2)108,8 ng/µlAugust 4
pSB1A2fcs + rbspurified plasmid (C1)113,9 ng/µlAugust 4
pSB1A2Sam5 + rbsreceived from EdinburghAugust 3
pSB1A2Sam5 + rbs, PstI site removedpurified plasmid (A2)101,3 ng/µlAugust 5
pSB1A2Sam8 + rbspurified plasmid (A1)95,7 ng/µlAugust 5
pSB1A2Sam8 (b)purified plasmid81,5 ng/µlAugust 5
pSB1A2COMTpurified plasmid (B2)122,9 ng/µlAugust 5
pSB1A2COMT + rbsplasmid from registry0 µlAugust 6
pSB1A2ech + rbspurified digest16,9 ng/µlAugust 6
fcs + rbspurified digest16,6 ng/µlAugust 6
pSB1A2sam5 + rbspurified digest3,1 ng/µlAugust 7
sam8 + rbspurified digest3,4 ng/µl August 7
pSB1A2fcs + rbspurified plasmid (fcs pl.)41 µl57,2 ng/µlAugust 12
pSB1A2Sam5 + rbspurified plasmid (sam5 pl.)43 µl76,0 ng/µlAugust 12
pSB1A2Sam8 + rbspurified plasmid (sam8 pl.)17 µl45,2 ng/µlAugust 12

vanillin receptor

part plasmid description status μl left concentration date
pSB1A2ech + rbspurified plasmid108,8 ng/µlAugust 4
pSB1A2fcs + rbspurified plasmid113,9 ng/µlAugust 4
pSB1A2Sam5 + rbsreceived from EdinburghAugust 3
pSB1A2Sam5 + rbs, PstI site removedpurified plasmid101,3 ng/µlAugust 5

miscellaneous

part plasmid description status μl left concentration date
dNTP mixATP, GTP, TTP, CTP9410μMaug 10
pSB1A2medium constitutieve promoterjuly 23
ampicilline